APRIL also plays an important role in understanding the relationships that underlie diseases such as multiple myeloma (MM), as it is one of the most important ligands for the BCMA receptor, for which an antibody has been used in MM therapies [22]. This evidence concerns the gene TNFSF13 and plasma cell myeloma.